Company page

Eloxx Pharmaceuticals, Inc.

Eloxx Pharmaceuticals, Inc. is a public company traded under the ticker ELOX in the American market. The company has a market capitalization of approximately $567 million. Eloxx focuses on developing innovative therapies to treat genetic diseases caused by nonsense mutations.